等待開盤 09-17 09:30:00 美东时间
-0.330
-1.38%
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing efficiently, Cohort 4 open for enrollmentSEATTLE, WA
09-16 20:33
Frontline ( ($FRO) ) has provided an announcement. Lars H. Barstad, CEO of Fron...
09-13 05:09
截至2025年9月11日13:02,中证沪港深游戏及文化传媒指数(931580)成分股方面涨跌互现,华图山鼎(300492)领涨10.69%,岩山科...
09-11 13:10
登录新浪财经APP 搜索【信披】查看更多考评等级 影响股市利好与利空消息 宏观新闻 1、中共中央政治局委员、国务院副总理何立峰9月...
09-11 07:19
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Frontline (FRO)的业绩会实录,我总结以下财务业绩回顾:</p> <p>• 财务业绩: - 第二季度调整后利润为8040万美元,每股0.36美元 - 第二季度TCE(等效期租)收入为2.83亿美元 - 截至2025年6月30日,现金和现金等价物为8.44亿美元 - 第二季度VLCC船队TCE收益率为43,100美元/天 - 第二季度Suezmax船队TCE收益率为38,900美元/天 - 第二季度LR2/Aframax船队TCE收益率为29,300美元/天</p> <p>• 财务指标变化: - 调整后利润环比增
09-03 12:08
Frontline (NYSE:FRO) +1.2% in Friday's trading, pushing into positive territory after reporting mixed Q2 results, with adjusted earnings missing estimates and revenues that topped expectations, while ...
08-30 03:28
Jefferies analyst Omar Nokta maintains Frontline (NYSE:FRO) with a Buy and maintains $25 price target.
08-29 21:05
Frontline plc (NYSE: FRO) reported Q2 2025 profit of $77.5 million, down 59% from last year but up from Q1. Revenue was $480.1 million, beating estimates.
08-29 19:55
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is estimated to repo...
08-29 16:32
Frontline (NYSE:FRO) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.47 by 24.05 percent. This is a 41.94 percent decrease over earnings of $0.62 per share from the same
08-29 15:58